Logo
x

Search

Subscribe Now

Sema4

Sema4 Signs a Definitive Agreement to Acquire GeneDx for ~$623M

Sema4 Signs a Definitive Agreement to Acquire GeneDx for ~$623M

  • January 20, 2022
BioSymetrics Signs an Agreement with Janssen and Sema4 to Utilize AI for the Prediction of COVID-19

BioSymetrics Signs an Agreement with Janssen and Sema4 to Utilize AI for the Prediction of COVID-19

  • August 20, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.